Replies to post #260038 on Innovation Pharmaceuticals Inc (IPIX)

[joseytheoutlawwales]

Still all here, except for Biomanbaba (RIP), just ignoring the noise of this board, which became mostly useless 2-3 years ago.

[Mrgreenfinger]

two words "Earnings Multiplier"

The average P/E ratio for the drugs sector of 24.10 is higher than the average P/E ratio for the broader health care sector, currently at 16.35. The drugs sector average is comprised of P/E ratios from a number of small-, mid- and large-cap drug manufacturers, including Biostar Pharmaceuticals (Nasdaq: BSPM) with a P/E ratio of 7.62, GlaxoSmithKline (NYSE: GSK) with a P/E ratio of 44.42 and AstraZeneca PLC (NYSE: AZN) with a P/E ratio of 74.41

if that .50 a share is inline with potential future earnings it's all about what P/E Multiplier we get.

let say on the low end .50 earning a share and a P/E of 15x (low end) = 7.5 a share for B-OM ONLY not including anything else or potential cash on hand or other partnerships or drugs in the pipeline.

[Lemoncat]

Well, that's a $120B market cap assuming we're still around 225M shares fully diluted. So yeah, I think that's a ways off if not long gone.